WMB
58
3
PLD
35
5
BAX
38
2
HBAN
47
7
GILD
55
5
CVS
27
2
PCG
59
9
PRU
39
3
EMR
57
7
CNX
67
4
IP
53
3
MHK
25
5
ADBE
50
3
MDLZ
28
2
VTR
44
4
CMI
49
2
OMC
37
2
VNO
46
6
PNC
48
6
HPE
48
2
WMB
58
3
PLD
35
5
BAX
38
2
HBAN
47
7
GILD
55
5
CVS
27
2
PCG
59
9
PRU
39
3
EMR
57
7
CNX
67
4
IP
53
3
MHK
25
5
ADBE
50
3
MDLZ
28
2
VTR
44
4
CMI
49
2
OMC
37
2
VNO
46
6
PNC
48
6
HPE
48
2
Financhill
Back

Cemex SAB de CV 10K Form

Buy
76

CX
Cemex SAB de CV

Last Price:
$5.65
Seasonality Move:
3.8%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive CX News And Ratings

See the #1 stock for the next 7 days that we like better than CX

CX Financial Statistics

Sales & Book Value

Annual Sales: $17.4B
Cash Flow: $0
Price / Cash Flow: 0
Annual Sales: $8.34
Price / Book: 0.68

Profitability

EPS (TTM): 0.29740
Net Income (TTM): $449.3M
Gross Margin: $5.9B
Return on Equity: 3.67%
Return on Assets: 1.6%

Cemex SAB de CV Earnings Forecast

Key Cemex SAB de CV Financial Ratios

  • The Gross Profit Margin over the past 28 years for CX is 33.71%.
  • The Selling, General & Administrative Expenses for CX have been equal to 7.99% of Gross Profit Margin.
  • The Research & Development expenses have been 0.00% of Revenue.
  • The Interest Expense is 315.93% of Operating Income.
  • The Net Earning history of CX is 1.05% of Total Revenues.
  • Per Share Earnings over the last 28 years have been positive in 13 years.

Cemex SAB de CV Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NYSE
Industry: Construction Materials
Sector: Materials
Current Symbol: CX
CUSIP: 151290
Website: cemex.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0.98
Quick Ratio: 0.5

Price-to-Earnings

Trailing P/E Ratio: 45.94
Forward P/E Ratio: 7.4

CX Technical Analysis vs Fundamental Analysis

Buy
76
Cemex SAB de CV (CX) is a Buy

Is Cemex SAB de CV a Buy or a Sell?

  • Cemex SAB de CV stock is rated a Buy
    The current Cemex SAB de CV [CX] share price is $5.65. The Score for CX is 76, which is 52% above its historic median score of 50, and infers lower risk than normal.